PVCT Well, I would like to hear something. It's been to long. I was looking at the calender on Provectus Website. February is a busy month in the industry. http://www.provectusbio.com/calendar-of-events/2/2017 According to the PR released on 12/22/2016; (2 events) Clinical Interventional Oncology (CIO) on February 4-5, 2017
Asian Pacific Association for the Study of the Liver (APASL) on February 15-19, 2017
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company ("Provectus" or "The Company"), today announced acceptance of two abstracts for poster presentations at international oncology conferences in February 2017. Both abstracts describe data from the Company's phase 1 study of PV-10 in tumors of the liver (https://www.clinicaltrials.gov/ct2/show/NCT00986661). http://www.provectusbio.com/news/press-releases
I haven't searched any of the events to see if I could find who is presenting, or if a schedule is even provided. I'm really not interested. Just looking for an update. I hope this situation between BOD, and Execs does not interfere. Time to GROW UP Provectus Bio pharmaceuticals Inc...geeze. The Ph.D on the end of their names should mean something. GLTA